Literature DB >> 6165370

Reactivity of lymphocytes to basic proteins prepared from brain glioma and stomach cancer with MEM test.

Y D Shi, Z S Tang, Z J Lian, C Z Lu, B G Xiao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165370      PMCID: PMC2010638          DOI: 10.1038/bjc.1981.76

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

Review 1.  Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.

Authors:  L Cercek; B Cercek
Journal:  Eur J Cancer       Date:  1977-09       Impact factor: 9.162

2.  The macrophage electrophoretic migration test in cancer.

Authors:  A H Goldstone; L Kerr; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

3.  Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

4.  The chemical nature of cancer basic protein.

Authors:  J P Dickinson; E A Caspary
Journal:  Br J Cancer Suppl       Date:  1973-08

5.  Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Br J Cancer Suppl       Date:  1973-08

6.  Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.

Authors:  E J Field; E A Caspary; K S Smith
Journal:  Br J Cancer Suppl       Date:  1973-08

7.  The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.

Authors:  A W Preece; P A Light
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

8.  Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.

Authors:  P A Light; A W Preece; H A Waldron
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

9.  Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.

Authors:  Y Hashimoto; F Takaku; T Yamanaka
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

10.  Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.

Authors:  J B Shelton; C W Potter; I Carr
Journal:  Br J Cancer       Date:  1975-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.